Check Every Claim

 Quick Explanation Copied

 Long Explanation

Profile and Citation Impact

Paweł Cięszczyk (ORCID 0000-0002-7735-7580) has 222 indexed works, ~4,544 citations, and an h-index of 35, with sustained productivity from 2009–2025 (peak output: 19 works in 2019 and 2021) OpenAlex bibliometric record. Citation flow peaked around 2014–2019 (455–584/year) and has declined since (~98 in 2024, ~38 in 2025), a pattern typical as early candidate-gene work ages past its citation half-life.

Key Scientific Contributions

His most-cited work is a large-scale GWAS on hand grip strength loci in Nature Communications, contributing to muscular fitness genetics Hand grip strength GWAS (Nature Communications). He co-authored a rigorous multi-cohort study showing ACTN3 R577X and ACE I/D effects on elite sprint performance with quantitative measures, directly addressing the small-sample weaknesses of earlier candidate-gene work ACTN3/ACE elite sprinter study. Importantly, he also contributed to null-result papers — finding no common DNA variant profile specific to world-class endurance athletes and no association of ACTN3/ACE with endurance running times in 698 athletes — evidence of willingness to publish negative findings against the field's positive-result bias No common endurance athlete variant profileACTN3/ACE endurance null result. Additional contributions span collagen gene variants and ACL rupture risk COL1A1 and ACL injury study, PPARGC1A Gly482Ser in Polish/Russian athletes PPARGC1A Gly482Ser athlete study, circulating microRNAs as exercise biomarkers Exercise miRNA review, and athlete gut microbiota Endurance athlete gut microbiota study.

Critical Assessment and Blind Spots

Strengths: consistency (20+ years of output), international consortium participation, recruitment of rare elite-athlete cohorts, and co-authorship on both positive and negative results — a marker of epistemic credibility in a field rife with p-hacking and small underpowered studies ACTN3 across elite European athletes. Limitations: he appears almost exclusively as middle author on top works, so individual scientific leadership is harder to attribute; the field's candidate-gene associations historically suffered replication failures and population stratification, meaning effect sizes across his portfolio are likely inflated by early-literature publication bias; ACL/collagen findings rest on moderate-strength association designs without mechanistic validation; and no primary institution is reliably indexed, complicating attribution. Peak citation years (2014–2019) largely reflect association studies whose effect sizes are now viewed skeptically in sports genomics, so his metrics partially inherit field-wide over-optimism. Overall: a solid, high-productivity contributor with strong collaboration networks, but evidence of first-author paradigm-shifting work is limited.

 BGPT Author Review

Scientific Quality

Productive sports genomics researcher (h-index 35, 222 works, 4.5k citations) embedded in strong international consortia (GWAS, multi-cohort ACTN3/ACE studies, athlete microbiome). Scores tempered by consistent middle-author positioning on flagship papers, a candidate-gene association portfolio known for replication fragility and inflated early effect sizes, and limited evidence of independent paradigm-setting leadership. Publishing null results is a genuine credibility plus.

Communication Quality

Papers target specialist genetics and sports-science journals with clear, well-structured aims (e.g., explicitly framing cohort limitations in abstracts). No evidence of broad-audience writing, reviews aiming at conceptual clarification, or exceptional pedagogical clarity; communication is competent but field-conventional.

Author Novelty

Work extends established candidate-gene paradigms (ACTN3, ACE, collagen, PPARGC1A) to new cohorts and adds newer directions (athlete microbiome, miRNA biomarkers), which is incremental rather than groundbreaking. Participation in the grip-strength GWAS and rigorous multi-cohort designs adds moderate novelty within an otherwise well-trodden space.

Scientific Rigor

Notably rigorous for his field: multi-cohort designs with quantitative performance measures, large athlete samples (e.g., 698 athletes), willingness to report null associations, and direct acknowledgment of prior small-sample/ethnic-confounding weaknesses. Rigor capped by reliance on association-only designs, no indexed mechanistic follow-up, and the inherent replication fragility of candidate-gene sports genomics.